Jackson Square Capital
MRK icon

Jackson Square Capital’s Merck MRK Stock Holding History

Jackson Square Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.27M Buy
36,297
+1,611
+5% +$223K 0.79% 31
2026
Q2 		$4.46M Sell
34,686
-281
-0.8% -$32.9K 0.62% 37
2026
Q1 		$4.21M Buy
34,967
+25,266
+260% +$2.92M 0.88% 29
2025
Q4 		$1.02M Buy
+9,701
New +$911K 0.2% 71
2025
Q1 		– Sell
-6,164
Closed -$613K – 157
2024
Q4 		$613K Sell
6,164
-15,684
-72% -$1.62M 0.15% 104
2024
Q3 		$2.48M Sell
21,848
-31,156
-59% -$3.7M 0.62% 42
2024
Q2 		$6.56M Buy
53,004
+760
+1% +$97.9K 1.61% 15
2024
Q1 		$6.89M Buy
52,244
+15,615
+43% +$1.92M 1.77% 15
2023
Q4 		$3.99M Buy
36,629
+79
+0.2% +$8.2K 1.28% 22
2023
Q3 		$3.76M Sell
36,550
-8,976
-20% -$967K 1.51% 22
2023
Q2 		$5.25M Sell
45,526
-450
-1% -$51.1K 2.11% 15
2023
Q1 		$4.89M Buy
45,976
+39,119
+570% +$4.22M 2.19% 13
2022
Q4 		$761K Sell
6,857
-13
-0.2% -$1.33K 0.36% 66
2022
Q3 		$592K Buy
6,870
+76
+1% +$6.78K 0.29% 70
2022
Q2 		$619K Sell
6,794
-31
-0.5% -$2.75K 0.26% 73
2022
Q1 		$560K Sell
6,825
-860
-11% -$67.8K 0.17% 105
2021
Q4 		$589K Buy
7,685
+3,875
+102% +$309K 0.17% 112
2021
Q3 		$286K Buy
3,810
+946
+33% +$71.9K 0.09% 153
2021
Q2 		$223K Sell
2,864
-5,431
-65% -$404K 0.07% 171
2021
Q1 		$610K Sell
8,295
-22,883
-73% -$1.69M 0.23% 82
2020
Q4 		$2.43M Sell
31,178
-3,714
-11% -$284K 0.94% 38
2020
Q3 		$2.76M Sell
34,892
-3,057
-8% -$239K 1.22% 35
2020
Q2 		$2.8M Buy
37,949
+25,114
+196% +$1.89M 1.41% 28
2020
Q1 		$942K Buy
12,835
+1,918
+18% +$151K 0.73% 45
2019
Q4 		$947K Buy
+10,917
New +$897K 0.55% 57

Other funds holding MRK

Smead Capital Management
Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Quilter Plc
Quilter Plc London, United Kingdom $6.95B AUM 39.67% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Jackson Square Capital's MRK Position: Q3 2026 in Review

Jackson Square Capital increased its Merck (MRK) stake by 4.6% in Q3 2026, buying an estimated $223K and bringing the position to 36,297 shares worth $5.27M. The position accounts for 0.79% of the portfolio, ranked #31.

Jackson Square Capital first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. The position peaked at $6.89M in Q1 2024. 1,024 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Jackson Square Capital held 36,297 shares of Merck worth $5.27M as of Q3 2026.
  • Jackson Square Capital bought 1,611 Merck shares in Q3 2026, an estimated $223K.
  • Merck made up 0.79% of Jackson Square Capital's portfolio in Q3 2026, its #31 holding.
  • Jackson Square Capital first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
  • Jackson Square Capital's Merck position peaked at $6.89M in Q1 2024.
  • 1,024 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.